- 3 days & nights inpatient stay
- 1 quick follow-up appointments
Participants will be reimbursed $1,100 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
This study is developing an anti-fibrotic drug to potentially be a new treatment for eye conditions that are caused by fibrosis (formation of scar tissue) and inflammation.
Unlike many other drugs for eye conditions, this medication can be taken orally instead of being injected or applied directly to the eye as drops, which would make it a more convenient and easier drug to use.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at firstname.lastname@example.org quoting “Sight Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!